EGFR expression levels affect the mode of action of egfr-targeting monoclonal antibodies

7Citations
Citations of this article
30Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Epidermal growth factor receptor (EGFR) expression levels appear to modulate the efficacy of EGFR-targeting monoclonal antibodies. More specifically, we observed that high EGFR densities negatively affect the effects of EGFRspecific antibodies on EGFR phosphorylation yet exacerbate Fc-mediated tumor-cell killing. These results suggest that the predominant mode of action of EGFR-targeting antibodies depend on EGFR expression levels. © 2013 Landes Bioscience.

Cite

CITATION STYLE

APA

Derer, S., Lohse, S., & Valerius, T. (2013). EGFR expression levels affect the mode of action of egfr-targeting monoclonal antibodies. OncoImmunology, 2(5). https://doi.org/10.4161/onci.24052

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free